Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Lemaitre Vascular (LMAT) Long-Term Debt Repayments (2010 - 2021)

Lemaitre Vascular (LMAT) reported Long-Term Debt Repayments of $78.0 million for Q4 2021, up 1660.0% year-over-year from $4.4 million in Q4 2020, and up 439.13% on a QoQ basis from -$23.0 million in Q3 2021.

Lemaitre Vascular (LMAT) has 4 years of Long-Term Debt Repayments data on file, last reported at $78.0 million in Q4 2021.

  • Quarterly Long-Term Debt Repayments rose 1660.0% year-over-year to $78.0 million in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $78.0 million (up 277.27% YoY) and the FY2021 annual result came in at $39.0 million, up 4000.0% from the prior year.
  • Long-Term Debt Repayments rose to $78.0 million in Q4 2021 per LMAT's latest filing, from -$23.0 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $78.0 million in Q4 2021 and bottomed at -$23.0 million in Q3 2021.
  • The 3-year median for Long-Term Debt Repayments is -$5.0 million (2020), against an average of $6.0 million.
  • Peak annual rise in Long-Term Debt Repayments reached 1660.0% in 2021, while the deepest fall reached 675.0% in 2021.
  • Tracing LMAT's Long-Term Debt Repayments over 3 years: stood at $4.0 million in 2019, then slumped by 225.0% to -$5.0 million in 2020, then soared by 1660.0% to $78.0 million in 2021.
  • Per Business Quant, the three latest LMAT Long-Term Debt Repayments figures stand at $78.0 million (Q4 2021), -$23.0 million (Q3 2021), and -$9.0 million (Q2 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 2.00 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 904.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 127.93 Mn
10 Lemaitre Vascular 2.28 Bn 1.91 Bn 48.40 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 78.00 Mn
Dec 31, 2021 78.00 Mn
Sep 30, 2021 -23.00 Mn
Sep 30, 2021 -23.00 Mn
Jun 30, 2021 -9.00 Mn
Jun 30, 2021 -9.00 Mn
Mar 31, 2021 -7.00 Mn
Mar 31, 2021 -7.00 Mn
Dec 31, 2020 -5.00 Mn
Dec 31, 2020 -5.00 Mn
Sep 30, 2020 4.00 Mn
Sep 30, 2020 4.00 Mn
Sep 30, 2019 4.00 Mn
Sep 30, 2019 4.00 Mn
Dec 31, 2010 -3,000.00
Dec 31, 2010 -3,000.00
Sep 30, 2010 -2,000.00
Sep 30, 2010 -2,000.00